Perfecting the Sense of Sight.
Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, refractive as well as cataract surgery. The company has raised approximately $18 million in financing from Stonehenge Growth Equity, Armory Square Ventures, Cranberry Capital, and prominent angel investors as well as the National Science Foundation. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories including LASIK. The contact lens and non-invasive refractive surgery products are currently in clinical development.
Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, refractive as well as cataract surgery. The company has raised approximately $18 million in financing from Stonehenge Growth Equity, Armory Square Ventures, Cranberry Capital, and prominent angel investors as well as the National Science Foundation. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories including LASIK. The contact lens and non-invasive refractive surgery products are currently in clinical development.
Location: United States, Florida
Employees: 51-200
Phone: +1 941-739-1382
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Cranberry ... | crancap.co... |
| - | Topmark Pa... | topmarkpar... |
Mentions in press and media 2
| Date | Title | Description |
| 29.05.2017 | 5 medtech companies to watch at JLABS @ Toronto | Like a blood test looking for biological markers, WinterLight’s technology seeks to isolate cadence, word choice and other voice markers that might indicate a neurological issue. “Different disorders have different clusters of variables ass... |
| - | 5 medtech companies to watch at JLABS @ Toronto | With more than 40 companies on its roster, Johnson & Johnson Innovation’s life sciences incubator JLABS @ Toronto is celebrating a successful first year. One of eight such facilities around North America, JLABS provides early stage star... |